There have been recent advances in the management of CF, in particular in the last 5 years following approval of cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators by the ...

STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN ...

A live webcast of the presentation will be available the day of the event on the "Events” page within the Investors section ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

Given coffee ingredients’ versatility, experts highlight how beverage-makers are developing new products with enhanced ...

The silicon photonics market is estimated to grow at a remarkable Compound Annual Growth Rate (CAGR) of over 26.0% between 2022 and 2032. This indicates that the market is anticip ...

STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) ), a pharmaceutical company that develops candidate drugs for ...

GPS technology, the backbone of navigation systems from smartphones to drones, relies on atomic clocks in satellites to ...

Purdue and Chalmers researchers develop microcomb technology, miniaturizing optical atomic clocks for enhanced precision in ...

The 2nd ADC Payload Summit (May 6-8 | Boston, MA). This is the first and only conference exclusively focusing on ADC payloads ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...